학술논문
A short washout period from fingolimod to anti-CD20 therapy is safe and decreases the risk of reactivation
Document Type
Short Communication
Author
Source
In Revue Neurologique November 2023 179(9):1035-1038
Subject
Language
ISSN
0035-3787